Drug Type Biosimilar, Monoclonal antibody |
Synonyms LusiNEX, Tocilizumab Biosimilar (Mycenax Biotech, Inc.), 托珠单抗生物类似药(永昕生物医药股份有限公司) + [3] |
Target |
Action antagonists |
Mechanism IL-6RA antagonists(Interleukin-6 receptor alpha subunit antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Phase 3 | Japan | 01 Jan 2023 |